Legal

Duodenoscope Superbug Infection Lawsuit 2026: ERCP Scopes, CRE and Who Can Be Sued

Daylongs ·
#Duodenoscope #ERCP #CRE Infection #Superbug #Product Liability #Hospital Negligence #Medical Device Lawsuit #Endoscope Reprocessing

What is a duodenoscope superbug infection lawsuit?

A duodenoscope superbug infection lawsuit is a civil claim by a patient who picked up a drug-resistant infection, usually CRE, after an ERCP procedure with a scope that carried bacteria from an earlier patient. It can target the scope maker, the hospital, or both.

The idea sounds simple. The proof is not. Almost every patient who gets one of these infections is already sick enough to need an ERCP, so the defense will argue that the infection came from the patient’s own gut, not the scope. Winning means answering that argument with records, lab work, and expert testimony.

This guide is written for US readers. It is general information, not legal advice, and I have not seen your records.

Why can a scope that was cleaned still spread infection?

A duodenoscope has a tiny lever at the tip, called the elevator, that angles instruments into the bile duct. Tissue and bacteria can lodge in and behind it, and standard cleaning does not always reach them.

FDA first warned the public in its safety communications on infections associated with reprocessed duodenoscopes that the complex design can make reprocessing difficult, and that infections have occurred even when facilities followed the manufacturer’s instructions. That last point matters for a lawsuit. It shifts attention from “someone skipped a step” toward “the design itself may not be cleanable.”

Cleaning a duodenoscope has several stages: wiping and flushing right after use, manual brushing, a washer-disinfector cycle, drying, and storage. A failure at any stage can leave a film behind. Hospitals also differ in how well they audit staff, track which scope went to which patient, and culture scopes for leftover bacteria.

What happened in the outbreaks that put this on the map?

Between 2013 and 2015, several US hospitals reported clusters of CRE infections tied to duodenoscopes, and FDA issued its first safety communication on the problem in 2015. Reports at the time named UCLA’s Ronald Reagan medical center and Virginia Mason in Seattle. Counts of infected patients and deaths varied between news reports and I have not checked them against hospital or court records, so I leave the numbers out.

A 2016 minority staff report from Senator Patty Murray’s office on the Senate health committee, titled “Preventable Tragedies,” blamed manufacturers, hospitals and FDA for failures in reporting and oversight. I read summaries of it, not the PDF, and it was a minority staff report rather than a committee finding.

Later, FDA moved from cleaning advice to design advice. The table below gives the rough sequence as I understand it from FDA’s own page and news coverage.

PeriodWhat happenedHow sure I am
2013-2015Hospital outbreaks of CRE linked to ERCP scopesReported widely; counts vary by source
Feb 2015FDA safety communication on difficult reprocessingFDA page confirmed in search
Jan 2016Senate minority staff reportSeen only in summaries
Apr 2022FDA recommends transition to disposable-component or fully disposable scopesFDA update confirmed in search
2022 onwardFDA-ordered surveillance studies on newer designsFinal results not found by me

What is CRE, and why do doctors fear it?

CRE stands for carbapenem-resistant Enterobacterales, a group of gut bacteria that resist carbapenems, among the strongest antibiotics hospitals have. CDC says CRE spreads in healthcare settings and can cause infections that are very hard to treat.

On its CDC page about CRE, the agency reported about 13,100 infections in hospitalized patients and roughly 1,100 deaths in the US in 2017. That figure is old, so check the CDC page for newer numbers. Bloodstream CRE infections carry especially high death rates in some state health department summaries, though your own risk depends on your health and how fast treatment starts.

For a lawsuit, the practical point is that CRE is traceable. Labs can often compare the strain in a patient with strains found in a scope or in other patients. That kind of match is the strongest evidence in these cases.

Who can be sued: the manufacturer, the hospital, or both?

Usually both are considered, and each faces a different kind of claim. The manufacturer is judged on the scope’s design and warnings. The hospital is judged on how it cleaned, tracked and disclosed.

DefendantTypical theoryWhat you would need to showMain hurdle
Scope manufacturerDesign defect; failure to warn; manufacturing defectThe design could not be reliably cleaned, or warnings were late or incompleteProving the specific scope caused your infection
Hospital or clinicNegligence in reprocessing, auditing or patient noticeA breach of the standard of care that caused harmExpert testimony and, in some states, shorter deadlines
Reprocessing vendor or staffing companyNegligence, breach of contractA named outsourced role failedFinding out who actually did the cleaning
Washer-disinfector or brush makerProduct liabilityThe accessory failed or had bad instructionsOften a smaller piece of the case

A few state-law points shape these suits. Because most duodenoscopes reached the market through FDA’s 510(k) clearance route rather than full premarket approval, the strongest federal preemption defense generally does not apply the way it does for some other devices. Courts still disagree on particular claims, so that is a question for your lawyer, not a promise.

Hospitals sometimes argue that the scope maker is the real culprit. Manufacturers argue the hospital did not follow the instructions. Expect that finger-pointing and plan for it by suing both when the records support it.

How do I prove the scope caused my infection?

You build a chain: you had the procedure, a specific scope was used, that scope was contaminated or part of a known problem, and the organism that infected you matches. Each link needs paper.

Start with timing. CRE infection symptoms such as fever, chills, abdominal pain or jaundice after ERCP, with a positive culture days later, fit the pattern. Timing alone is weak, though, because bile duct disease and surgery carry infection risk of their own.

Stronger evidence includes:

  • A culture result naming the organism and its resistance pattern.
  • The scope’s serial number and its reprocessing history.
  • Hospital surveillance cultures from scopes, if any were taken.
  • A hospital or health department outbreak notice listing affected patients.
  • Genetic comparison (strain typing) between your sample and a scope or other patients.

Defense lawyers will point to everything else that could have caused it: antibiotics you took earlier, a long hospital stay, an existing bile duct blockage. A good plaintiff’s expert explains why the scope remains the most likely source and why the alternatives fit worse.

What records should I ask for, and how?

Request your own records in writing, early, before memories fade and before retention schedules delete anything. The federal HIPAA right of access, described on the HHS page on access to health information, lets you get a copy of your medical record, and providers generally must respond within 30 days.

RecordWhy it mattersWho holds it
Full chart and discharge summaryShows indications, complications and timingHospital or clinic
Procedure note and endoscopy logNames the scope and the teamEndoscopy unit
Scope make, model, serial numberLinks your case to a specific deviceEndoscopy or sterile processing
Reprocessing log for that scopeShows each cleaning cycle and who did itSterile processing
Culture and lab resultsProves the organism and resistanceLab, via the hospital
Exposure or recall noticesShows what the hospital knew and whenInfection control, risk management

Some of these, such as reprocessing logs and internal investigations, may not be released on a simple request. That is where a lawsuit’s discovery phase comes in, and where lawyers may use preservation letters to stop records from being discarded.

Also keep your own paper: medication lists, bills, pay stubs, and a dated symptom diary.

What does a realistic case look like, and when do claims fail?

Composite example

This is a composite, not a real case, built to show how the pieces fit.

A 58-year-old man has an ERCP to remove a bile duct stone. Nine days later he has a fever and goes to the emergency room, where a blood culture grows a carbapenem-resistant bacterium. He spends three weeks in the hospital, part of it in intensive care, on strong IV antibiotics, and misses two months of work.

His lawyer requests the chart and finds the scope’s serial number. The reprocessing log for that scope shows a gap in manual cleaning on the day of his procedure. The hospital also quietly cultured the scope two months earlier and found a growth, yet kept using it. His case then has two stories: a design that is hard to clean, and a facility that missed warning signs.

The defense answers that he had a long-standing bile duct infection risk and took antibiotics before. His expert uses strain typing to show the bacterium in his blood matches the one found in the scope. The case then turns on that match, not on general fears about duodenoscopes.

Most real cases are messier. Often the match is missing or the scope was never cultured, and a lawyer may decline the case. That is a normal outcome, not a sign you did something wrong.

Where claims fall apart

They fail more often than advertising suggests. Three patterns come up repeatedly.

First, no proof of the scope. If nobody can say which scope was used, or the log is missing, the manufacturer’s lawyers say you cannot tie a specific device to your infection.

Second, late filing. A patient waits for symptoms to settle, then discovers the deadline passed. Some states run the clock from the date of the procedure, not from when you learned the cause.

Third, a plausible alternate source. If the patient was already colonized with CRE, which can happen after earlier hospital stays, the defense argues the scope added nothing.

None of these ends every case. They explain why the first call to a lawyer should include dates, not just a story.

What is the deadline to file, and when does the clock start?

Deadlines vary widely by state and by type of claim. Medical negligence claims often have shorter windows than product liability claims, commonly somewhere between one and six years depending on the state and the theory, and some states add a cutoff that runs from the procedure date no matter what you knew.

Many states apply a discovery rule, starting the clock when you knew, or reasonably should have known, that the scope caused your illness. Courts apply that rule differently, and a hospital letter about “possible exposure” can start it in some places.

Short notice rules matter too. Claims against government hospitals, such as county or Veterans Affairs facilities, may require a written notice within months, long before the ordinary deadline. Because of these traps, treat any deadline you read online as a reason to hurry, not as your deadline. Defective medical device lawsuit deadlines are covered in more detail in our device-litigation guide.

What can you recover in a contaminated duodenoscope case?

Recovery usually covers medical bills, future care, lost income, pain and suffering, and in death cases the damages allowed under your state’s wrongful death law. Punitive damages are possible against a manufacturer in some states if conduct was especially reckless, but they are hard to win.

I will not quote a typical verdict or settlement number, because I did not find a source I trust, and law firm marketing pages often mix outcomes. What I can say is what moves the value:

  • How long you were sick and whether you needed surgery or intensive care.
  • Lasting harm, such as organ damage, amputation, or permanent antibiotic complications.
  • Whether a family member died.
  • Strength of the link between your scope and your infection.
  • Insurance, liens and Medicare or Medicaid repayment, which reduce what you keep.

Medicare, Medicaid and private health plans may claim part of a settlement back. Ask your lawyer about liens before you accept a figure.

How does this compare with other hospital infection and device claims?

These cases sit between two familiar types. A claim over a hospital-acquired infection, like those in our hospital-acquired infection lawsuit guide, turns mostly on whether the hospital met its standard of care. A product case, like the one in our Bair Hugger surgical infection lawsuit update, turns mostly on the device and the science linking it to injury.

A scope case borrows from both. You may need a medical expert on cleaning practice and a device expert on design, and that raises cost. If your claim looks like ordinary negligence, read the medical malpractice lawsuit guide for how expert witnesses and damage caps work. For the hospital side specifically, our hospital negligence lawyer guide explains how facility liability is argued. And for the device side, see the product liability lawyer guide.

How do I choose a lawyer and what will it cost?

Look for a firm that has handled medical device or hospital infection cases and can name the experts it uses, rather than one that only advertises. Most plaintiff firms in this field work on contingency, which means no fee unless there is a recovery, with the percentage set in a written agreement. Percentages commonly sit around one third before trial and higher if the case goes to trial, but that varies, and costs for experts are separate.

Questions worth asking:

  • Have you handled a case where the scope was identified by serial number?
  • Who pays expert and testing costs if we lose?
  • Will you also evaluate a claim against the hospital, or only the manufacturer?
  • How do you handle liens?

Do not sign with the first firm that calls after you post about your illness. Compare two or three.

What should I do this week if I think I was exposed?

Start with your health. If you had an ERCP and have fever, chills, abdominal pain, yellow skin, or feel suddenly worse, get medical care and tell the clinician about the procedure.

Then take these steps:

  1. Request your records in writing, including the scope’s identifier.
  2. Save any letter from the hospital about exposure, and do not sign a release without legal advice.
  3. Report a suspected scope-related infection to FDA through MedWatch. A report is not a lawsuit, but it creates an official record.
  4. Write a dated timeline of symptoms, visits and bills.
  5. Talk to a lawyer before any deadline gets close.

One more point, because people ask. Hospitals sometimes call patients after an outbreak and offer to cover bills. Accepting help is fine, but read anything you are asked to sign.

This article is general information, not legal or medical advice. Laws, deadlines and FDA recommendations change, and I did not open every primary source linked or cited here. Confirm current rules with FDA and CDC and with a licensed attorney in your state.

What is a duodenoscope superbug infection lawsuit?

It is a civil claim by a patient who developed a drug-resistant infection, often CRE, after an ERCP procedure with a scope that was not fully cleaned. The claim can name the scope maker under product liability, the hospital or clinic for negligence, or both.

Which procedure uses a duodenoscope?

ERCP, endoscopic retrograde cholangiopancreatography. A flexible scope goes through the mouth to the opening of the bile and pancreatic ducts so doctors can remove stones, place stents, or take samples. Ordinary upper endoscopy and colonoscopy use different scopes.

Why are duodenoscopes hard to clean?

The tip has a tiny moving lever, the elevator, with crevices and a sealed channel around it. FDA has said this complex design can trap tissue and bacteria even when the maker's cleaning steps are followed exactly.

What infections have been linked to contaminated duodenoscopes?

FDA's safety communications describe multidrug-resistant infections, including CRE strains of Klebsiella and E. coli, linked to reprocessed duodenoscopes. Symptoms after ERCP such as fever, chills, or abdominal pain should be evaluated promptly.

Can I sue the hospital, the manufacturer, or both?

Often both. The manufacturer faces design-defect and failure-to-warn theories; the hospital faces negligence theories about reprocessing, tracking, and telling patients about exposure. Which defendant is stronger depends on the records, so a lawyer usually pleads both.

How do I prove my infection came from the scope?

You need a culture result, the identity of the scope used on you, and evidence tying the organism to that scope or to a documented outbreak, such as matching strains or hospital culture results. Chart records alone rarely settle it, so expert testing is common.

What is the deadline to file a duodenoscope infection lawsuit?

It depends on the state and the claim. Medical negligence deadlines are often shorter than product liability deadlines, and many states start the clock when you discover or should have discovered the cause. Do not guess; a lawyer should calendar it in the first week.

What records should I request after an ERCP infection?

Ask for your full chart, the procedure and endoscopy log, the scope's make, model and serial number, the reprocessing log for that scope, culture and lab results, and any exposure notice the hospital sent. HIPAA gives you a right to your own records.

How much is a duodenoscope infection lawsuit worth?

There is no reliable average, and this article cites no verdict figures. Value turns on severity, deaths or extra surgeries, medical bills, lost income, and proof of fault. Be wary of any lawyer who promises a number before reading your records.

Has FDA changed its advice on duodenoscopes?

Yes. In April 2022 FDA recommended that facilities move toward duodenoscopes with disposable components or fully disposable designs, while saying a sudden market withdrawal of older models was not feasible. Check FDA's current page for the latest.

공유하기

관련 글